🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

With the govt trying to track down protestors from yesterday’s gathering, is this not the perfect time to engage 20-30 year olds who know how to stalk people online like it’s a profession?! #COVID19Aus #COVIDIDIOTS #COVID19nsw #sydneyprotest #freedomrally #sydneylockdown

Great presentation and insights shared by NHMRC CTC Fellow ChenLee about the challenges of treating recurrent ovarian cancer. ANZGOG trials contribute to better understanding these challenges with a diverse research portfolio. Research is the key. #ANZGOGEducationSeries

The #HonourHer2021 campaign brings together Australian artists helping ANZGOG and WomenCan raise much needed funds for #GynaeCancer research. Affordable and collectible art for a cause 🎨Virtual gallery now open to purchase and online auction starts in 2 wks 🖼

Thanks to Western NSW LHD for their pop-up clinic in Mudgee Region today allowing me to get my three kids vaccinated. Efficiently organised with friendly & engaging staff. This makes going back to school in 3 weeks a little less stressful! #CovidVaccine #RegionalHealth #Mudgee

So grateful to be back in Melbourne for #anzgog2022asm. Cannot wait to reconnect with our inspirational world leading clinicians and researchers. Thanks for putting on a stunning first morning, Melbourne. What a picturesque start to the day! #anzgog #PathwaysToPrecisionCare

Congratulations Clare Scott on a fantastic achievement for SOLACE2! Many thanks from ANZGOG to all of the recruiting and referring clinicians, site staff and trial patients and their families - we couldn’t do this without you!

Was a highlight to see George Auyeung present his IGNITE poster in person at ASCO. Second only to witnessing how many attendees not only eagerly reviewed the content but also sought insights. It’s an honour to be a co-author on such important work. ANZGOG #ASCO2022

There’s only 1 week to go until ANZGOG’s FFNR closes! Research is the key for gynaecological cancer. If you have any questions or queries relating to your application, please contact me at [email protected].

Congrats on another milestone George Auyeung. IGNITE is demonstrating how important precision medicine is for #ovariancancer & how this treatment approach benefits the patients participating in the important research we undertake at ANZGOG. It’s an honour to do this alongside you.

Another insightful publication from the PHAEDRA trial - a collaborative effort from ANZGOG and NHMRC CTC under the leadership of Yoland Antill. Each piece of learning from our trials brings us one step closer to #ImprovingLifeForWomen. Congratulations to my co-authors.

To my ANZGOG followers, don’t forget to nominate your fellow members for our Recognition Awards presented at our 2023 ASM. There are five categories to nominate your colleagues and/or collaborators in. We can’t wait to celebrate and showcase our amazing members!

Congratulations to all of the ANZGOG members who contributed to our grant 👏🏼 Now the fun begins as we get things rolling and start recruiting eligible endometrial cancer patients.

Kicking off the #ANZGOGASM2023 with an insightful session looking at the trials and tribulations of developing your research career. So many valuable lessons and advice being shared by the expert panel as well as those in the audience ANZGOG

What a whirlwind the last 3 days have been at the #ANZGOG2023ASM. It was inspirational, collegiate and best of all full of smiles and laughs. Can’t wait to do it again next year. A massive shout out to our whole amazing ANZGOG team who enable the research we undertake.

Another ASCO conference done & dusted. I appreciate the time I get to spend with our ANZGOG members in not only learning more about the latest treatment pathways & optimal treatment approaches, but also connecting & supporting one another through the development of our research

Congrats to the research team at ANZGOG for this significant milestone, and to Clare Scott for your tenacity and passion for changing outcomes for those affected by rare gynae cancer. Hopefully this will be the first patient of many to benefit from this treatment approach.

Grateful to have coauthored this important analysis looking at patient involvement within GCIG’s research. Hopefully the recommendations will be incorporated into future research undertaken by GCIG after demonstrating the value patient contributions can add to trial outcomes.

Honored to co-author this paper regarding patient involvement in the development of international gynaecological cancer clinical trials. Hopefully our recommendations & insights encourage higher rates of patient and carer involvement in ALL oncology trials, not just gynae.

Congratulations to George Auyeung on another significant milestone for IGNITE. Hopefully the first of many more patients with CCNE1 over-expression who may benefit from this targeted treatment approach!

After nearly 3 years of guessing the same starter word it finally came through! I feel like I can now have fun coming up with random words like everyone else I know who plays Wordle religiously. How lame is my life?! 😂